Abstract
Complement activation with pneumococcal antigens was studied both in vitro and after injection of the antigens into rats. Whole pneumococci of various serotypes activated C3-C9 in rat serum treated with ethyleneglycol-bis (β-aminoethyl ether)-N,N′-tetraacetic acid, although serotypes differed greatly in the extent of activation. Some purified pneumococcal capsular polysaccharides also activated C3-C9 in rat serum, but only when the antigens were present in concentrations of 500 to 1,000 μg/ml. Much of the activation with capsular polysaccharides was eliminated by the use of ethyleneglycol-bis (β-aminoethyl ether)-N,N′-tetraacetic acid. Activation of C3-C9 by capsular polysaccharides did not correlate with the level of reactivity observed with whole organisms of the same serotypes. After injection of 5 × 109 pneumococci (type 3 or type 4) intravenously into rats, there was a transient decline in serum C3-C9 activity, but there was no decline in C3-C9 levels after intravenous injection of 1,000 μg of type 3 or type 4 capsular polysaccharides. As determined by immunofluorescence, circulating capsular polysaccharide was deposited in several tissues, including the vascular endothelium and glomerular mesangium of the kidney. C3 was not detectable in these deposits, and there was no histological evidence of an inflammatory response. Capsular polysaccharides appear to be only weak activators of complement. Other pneumococcal antigens may be more important in the pathogenesis of hypocomplementemia in pneumococcal infection.
Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bitter-Suermann D., Hadding U., Schorlemmer H. U., Limbert M., Dierich M., Dukor P. Activation by some T-independent antigens and B cell mitogens of the alternative pathway of the complement system. J Immunol. 1975 Aug;115(2):425–430. [PubMed] [Google Scholar]
- Caldwell J. R., Ruddy S., Austen K. F. Assay of complement components C1, C4, C2, C3 and C9 in whole rat serum. Int Arch Allergy Appl Immunol. 1972;43(6):887–897. doi: 10.1159/000230906. [DOI] [PubMed] [Google Scholar]
- Coonrod J. D., Drennan D. P. Pneumococcal pneumonia: capsular polysaccharide antigenemia and antibody responses. Ann Intern Med. 1976 Mar;84(3):254–260. doi: 10.7326/0003-4819-84-3-254. [DOI] [PubMed] [Google Scholar]
- Coonrod J. D., Leach R. P. Antigenemia in fulminant pneumococcemia. Ann Intern Med. 1976 May;84(5):561–563. doi: 10.7326/0003-4819-84-5-561. [DOI] [PubMed] [Google Scholar]
- Coonrod J. D., Rylko-Bauer B. Complement levels in pneumococcal pneumonia. Infect Immun. 1977 Oct;18(1):14–22. doi: 10.1128/iai.18.1.14-22.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fine D. P. Pneumococcal type-associated variability in alternate complement pathway activation. Infect Immun. 1975 Oct;12(4):772–778. doi: 10.1128/iai.12.4.772-778.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hyman L. R., Jenis E. H., Hill G. S., Zimmerman S. W., Burkholder P. M. Alternative C3 pathway activiation in pneumococcal glomerulonephritis. Am J Med. 1975 Jun;58(6):810–814. doi: 10.1016/0002-9343(75)90636-1. [DOI] [PubMed] [Google Scholar]
- KAPLAN M. E., COONS A. H., DEANE H. W. Localization of antigen in tissue cells; cellular distribution of pneumococcal polysaccharides types II and III in the mouse. J Exp Med. 1950 Jan 1;91(1):15-30, 4 pl. doi: 10.1084/jem.91.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Macher A. M., Bennett J. E., Gadek J. E., Frank M. M. Complement depletion in cryptococcal sepsis. J Immunol. 1978 May;120(5):1686–1690. [PubMed] [Google Scholar]
- Mauer S. M., Sutherland D. E., Howard R. J., Fish A. J., Najarian J. S., Michael A. F. The glomerular mesangium. 3. Acute immune mesangial injury: a new model of glomerulonephritis. J Exp Med. 1973 Mar 1;137(3):553–570. doi: 10.1084/jem.137.3.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miyakawa Y., Sekine T., Shibata S., Nishioka K. Studies on rat complement: a method for titration of rat C1, C2, C3, C4, as well as C5, and the effect of rabbit nephrotoxic serum on the first five components of complement in rat serum. J Immunol. 1971 Feb;106(2):545–551. [PubMed] [Google Scholar]
- PILLEMER L., SCHOENBERG M. D., BLUM L., WURZ L. Properdin system and immunity. II. Interaction of the properdin system with polysaccharides. Science. 1955 Sep 23;122(3169):545–549. doi: 10.1126/science.122.3169.545. [DOI] [PubMed] [Google Scholar]
- Quinn P. H., Crosson F. J., Jr, Winkelstein J. A., Moxon E. R. Activation of the alternative complement pathway by Haemophilus influenzae type B. Infect Immun. 1977 Apr;16(1):400–402. doi: 10.1128/iai.16.1.400-402.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Reed W. P., Davidson M. S., Williams R. C., Jr Complement system in pneumococcal infections. Infect Immun. 1976 Apr;13(4):1120–1125. doi: 10.1128/iai.13.4.1120-1125.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stephens C. G., Williams R. C., Jr, Reed W. P. Classical and alternative complement pathway activation by pneumococci. Infect Immun. 1977 Aug;17(2):296–302. doi: 10.1128/iai.17.2.296-302.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Winkelstein J. A., Bocchini J. A., Jr, Schiffman G. The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus. J Immunol. 1976 Feb;116(2):367–370. [PubMed] [Google Scholar]
- Winkelstein J. A., Tomasz A. Activation of the alternative complement pathway by pneumococcal cell wall teichoic acid. J Immunol. 1978 Jan;120(1):174–178. [PubMed] [Google Scholar]
- Winkelstein J. A., Tomasz A. Activation of the alternative pathway by pneumococcal cell walls. J Immunol. 1977 Feb;118(2):451–454. [PubMed] [Google Scholar]
